North Penn adopts 2026–27 budget, cites Merck assessment uncertainty and $15M transfer to capital

The North Penn School District board approved the final fiscal 2026–27 budget and annual tax levy on June 18 after a finance presentation detailing adjustments since the proposed final.

Finance presenter Miss Hauser told the board the district moved from an estimated $757,000 deficit (before capital transfers) to a $33,000 surplus before transfers by adjusting revenue assumptions and expense lines. The presentation included a planned $15 million transfer from fund balance to capital projects.

Hauser said revenue changes reflected updated guidance about Merck’s assessed value and a recommendation from state representatives to record full county assessment while reserving a liability for potential adjustments. “So the revenue number looks like it significantly increased. It did, but it didn't,” Hauser said, explaining that a reserve (recorded at about $3.4 million) was set aside related to the Merck situation.

Other changes Hauser reported included rolling forward unspent federal grant funds (about $900,000) due to 15-month grant cycles, a $400,000 reduction tied to state reimbursement changes and reductions of approximately $304,000 from debt-accounting corrections. Extra-duty pay and reclassifications in salary coding also affected expense lines.

Board members asked how the Merck situation will appear in actuals next year. Hauser said it depends on negotiations with Merck — the tax bill will be issued at full assessed value on July 1 and revenue recognition will vary depending on whether Merck pays and later receives a refund or withholds payment until settlement.

The board adopted the final budget resolution and approved the tax levy for fiscal year 07/01/2026–06/30/2027 by voice vote. The meeting also authorized appointment of special counsel for the district’s tax-assessment litigation with Merck and approved related procedural actions.

The superintendent and board said they will continue finance committee work and return to the board with updates and adjustments as the Merck matter and other variables evolve.